Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 15.2.2021 | EN | Official Journal of the European Union | C 53/39 |

---

Judgment of the General Court of 16 December 2020 — Gustopharma Consumer Health v EUIPO — Helixor Heilmittel (HELIX ELIXIR)

(Case T-883/19) [(1)](#ntr1-C_2021053EN.01003901-E0001)

(EU trade mark - Opposition proceedings - Application for the EU word mark HELIX ELIXIR - Earlier EU word mark HELIXOR - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

(2021/C 53/52)

Language of the case: English

Parties

Applicant: Gustopharma Consumer Health, SL (Madrid, Spain) (represented by: A. Gómez López and J. Mora Cortés, lawyers)

Defendant: European Union Intellectual Property Office (represented by: L. Rampini and V. Ruzek, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Helixor Heilmittel GmbH (Rosenfeld, Germany) (represented by: J. Klink, lawyer)

Re:

Action brought against the decision of the First Board of Appeal of EUIPO of 23 October 2019 (Case R 100/2019-1) relating to opposition proceedings between Helixor Heilmittel and Gustopharma Consumer Health.

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Gustopharma Consumer Health, SL, to pay the costs. |

---

---

[Top](#document1)